Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage
Science Advances · 2025
DOI: 10.1126/sciadv.adv1988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Joanne Muter und 17 weiteren Autor:innen. Beteiligte Einrichtung: Warwick Medical School, Division of Biomedical Sciences, University of Warwick, CV4 7AL Coventry, UK. Hauptthemen laut MEDLINE: Decidua, Endometrium, Abortion, Spontaneous. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
In every menstrual cycle, progesterone acting on estrogen-primed endometrium elicits an inflammatory decidual reaction, rendering it poised for embryo implantation and transformation into the decidua of pregnancy. Here, we show that the sequential functions of the decidual reaction—implantation and decidualization—pivot on the time-sensitive loss of progesterone-resistant DIO2 + stromal cells that form a specialized implantation niche and reciprocal expansion of progesterone-dependent PLA2G2A + predecidual cells. Simultaneously, uterine natural killer (uNK) cell proliferation results in the accumulation of immunotolerant subsets. Examination of endometrial biopsies from 924 women revealed that the recurrence risk of miscarriage closely aligns with the incidence of a weakened or stalled decidual reaction, more so than poor uNK cell expansion. Analysis of paired biopsies obtained in different cycles and modeling in assembloids intimated that prior miscarriages disrupt intercycle endometrial homeostasis and calibration of the decidual reaction. Our findings show that erosion of the decidual reaction following a miscarriage drives the recurrence risk irrespective of maternal age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Warwick Medical School, Division of Biomedical Sciences, University of Warwick, CV4 7AL Coventry, UK.
- Tommy's National Centre for Miscarriage Research, University Hospitals Coventry & Warwickshire National Health Service Trust, CV2 2DX Coventry, UK.
- Research Group Genetics, Reproduction and Development, Vrije Universiteit Brussel, 1050 Brussels, Belgium.
- Department of Clinical Immunology Service, University of Birmingham, B15 2TT Birmingham, UK.
- Department of Cardiovascular Sciences, University of Leicester, LE1 7RH Leicester, UK.
- Tommy's National Centre for Miscarriage Research, Imperial College London, W12 0HS London, UK.
ORCID-Profile: Joanne Muter, Chow-Seng Kong, Mireia Taus Nebot, Pavle Vrljicak, Paul J Brighton, Danai B Dimakou, Megan Vickers, Hiroyuki Yoshihara, Sascha Ott, Bee K Tan, Phillip R Bennett, Siobhan Quenby, Alex Richter, Hilde Van de Velde, Emma S Lucas, Thomas M Rawlings, Jan J Brosens
Förderung
- Wellcome Trust
Zitieren
APA
Muter, J., Kong, C. S., Nebot, M. T., Tryfonos, M., Vrljicak, P., Brighton, P. J., Dimakou, D. B., Vickers, M., Yoshihara, H., Ott, S., Tan, B. K., Bennett, P. R., Quenby, S., Richter, A., Van de Velde, H., Lucas, E. S., Rawlings, T. M., & Brosens, J. J. (2025). Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage. Science Advances. https://doi.org/10.1126/sciadv.adv1988
Vancouver
Muter J, Kong CS, Nebot MT, Tryfonos M, Vrljicak P, Brighton PJ, et al. Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage. Science Advances. 2025. doi:10.1126/sciadv.adv1988
BibTeX
@article{Muter2025,
author = {Muter, Joanne and Kong, Chow-Seng and Nebot, Mireia Taus and Tryfonos, Maria and Vrljicak, Pavle and Brighton, Paul J and Dimakou, Danai B and Vickers, Megan and Yoshihara, Hiroyuki and Ott, Sascha and Tan, Bee K and Bennett, Phillip R and Quenby, Siobhan and Richter, Alex and Van de Velde, Hilde and Lucas, Emma S and Rawlings, Thomas M and Brosens, Jan J},
title = {Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adv1988}
}
EUVIMED